Akero Therapeutics Inc (AKRO) — Financial Flexibility Index
Akero Therapeutics Inc (AKRO) has a Financial Flexibility Index of -1.40x as of September 2025. Free cash flow of $-67.17 Million (operating CF $-67.17 Million minus capex $0.00) represents -1% of total liabilities ($47.94 Million). Check tangible net worth ratio of Akero Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akero Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Akero Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see AKRO cash flow conversion.
Annual Financial Flexibility Index for Akero Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Akero Therapeutics Inc. Explore debt repayment capacity of Akero Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.02x | $-229.11 Million | $-230.11 Million | $75.77 Million | ▲ +6.5% |
| 2023 | -3.23x | $-145.37 Million | $-145.37 Million | $44.97 Million | ▼ -4.9% |
| 2022 | -3.08x | $-92.52 Million | $-92.52 Million | $30.01 Million | ▼ -2.3% |
| 2021 | -3.01x | $-79.68 Million | $-79.68 Million | $26.44 Million | ▲ +37.6% |
| 2020 | -4.83x | $-70.66 Million | $-70.80 Million | $14.63 Million | ▼ -27.9% |
| 2019 | -3.78x | $-35.48 Million | $-35.63 Million | $9.39 Million | ▼ -128104.4% |
| 2018 | 0.00x | $375.00K | $-4.62 Million | $127.07 Million | ▲ +100.4% |
| 2017 | -0.81x | $-4.23 Million | $-4.38 Million | $5.22 Million | — |